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Background: Acute kidney injury (AKI) is one of the more serious complications 
after cardiac surgery. Elevated red cell distribution width (RDW) was reported as a 
predictor for cardiac surgery associated acute kidney injury (CSAKI). However, the 
increment of RDW by erythrocyte transfusion makes its prognostic role doubtful. The 
aim of this study is to elucidate the impact of erythrocyte transfusion on the 
prognostic role of elevated red cell distribution width (RDW) for predicting CSAKI. 
Methods: A total of 3207 eligible patients who underwent cardiac surgery during 
2016–2017 were enrolled. Changes of RDW was defined as the difference between 
preoperative RDW and RDW measured 24 h after cardiac surgery. The primary 
outcome was CSAKI which was defined by the Kidney Disease: Improving Global 
Outcomes Definition and Staging (KDIGO) criteria. Univariate and multivariate 
analysis were performed to identify predictors for CSAKI. 
Results: The incidence of CSAKI was 38.07% and the mortality was 1.18%. CSAKI 
patients had higher elevated RDW than those without CSAKI (0.65 vs. 0.39%, p < 
0.001). Multivariate regression showed that male, age, New York Heat Association 
Classification 3–4, elevated RDW, estimated glomerular filtration rate < 60 
mL/min/1.73 m2, CPB time > 120 min and erythrocyte transfusion were associated 
with CSAKI. Subgroup analysis showed elevated RDW was an independent predictor 
for CSAKI in the non-transfused subset (adjusted odds ratio: 1.616, p < 0.001) 
whereas no significant association between elevated RDW and CSAKI was found in 
the transfused patients (odds ratio: 1.040, p = 0.497). 
Conclusions: Elevated RDW is one of the independent predictors of CSAKI in the 
absence of erythrocyte transfusion, which limits the prognostic role of the former on 
predicting CSAKI.  
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Acute kidney injury (AKI) is one of the prevalent and severe complications after 
cardiac surgery. The mortality of patients who develop cardiac surgery associated 
acute kidney injury (CSAKI) or severe AKI with renal replacement therapy (RRT) 
required remains high [1]. The diagnosis of AKI is mainly based on serum creatine 
and urine output, whereas these functional markers are insufficient to predict AKI at 
an earlier stage. Therefore, new biomarkers have been studied for diagnosing AKI 
earlier [2–5]. Although new biomarkers for predicting AKI have been developed, they 
are expensive,  and restrain the prevalence of utilization in developing countries like 
India, Brazil and the Chinese mainland, where cardiac surgery is booming and AKI 
incidence is high. 
Red cell distribution width (RDW) is recognized as an index of erythrocyte 
volume variability and is routinely reported as a part of a complete blood cell count. 
Recently, its role of predicting CSAKI has been revealed [6, 7]. RDW is reported 
associating with inflammation or ischemia reperfusion injury [8, 9], and is likely to 
elevate after cardiac surgery, especially surgery with cardiopulmonary bypass [10]. 
Accordingly, postoperative elevated RDW is potentially associated with the oxidative 
stress and inflammation during operation and early phase of the postoperative period.  
Meanwhile, erythrocyte transfusion is performed widely in cardiac surgery and 
reported as a potentially modifiable risk factor for CSAKI [11]. Recent evidence 
suggests that RDW increases after erythrocyte transfusion [12]. However, little is 
known about whether the increment of RDW by transfusion will influence its value 
for predicting CSAKI.  
The purpose of the present study is to validate the role of elevated RDW 
predicting CSAKI and analyze whether or not its prognostic role is confounded by 
erythrocyte transfusion. 
 
MATERIALS AND METHODS  
Patient sample 
This study was approved by the ethical board of Zhongshan Hospital, Fudan 
4 
 
University (Approval Number B2017–039). Informed consent was obtained from all 
participants. Data from consecutive patients aged 18 years or older who underwent 
valve and/or coronary artery bypass grafting (CABG) surgery from January 2016 to 
December 2017 were included in this single-center cohort study. To reduce the 
confounding effect of acute life-threatening blood loss, patients who received plasma, 
platelet or more than four units of erythrocytes on the day of surgery were excluded. 
Other exclusion criteria were: transfusion of red blood cell (RBC) during the 28 days 
before enrollment, urgent surgery, preoperative mechanical ventilation or 
tracheotomy, preoperative defibrillator or ventricular assist devices, preoperative RRT, 
preoperative liver dysfunction, or sepsis. 
 
Data collection 
All perioperative data were prospectively collected and extracted retrospectively 
from the database of Zhongshan Hospital cardiac surgery. All data were checked twice 
by professional personnel before input into the database. Demographic and procedure-
related variables known to be associated with AKI were included in this study after a 
literature review. They included gender, age, comorbidities, contrast media exposure 
history, preoperative cardiac function status (New York heart association [NYHA] 
classification), baseline estimated glomerular filtration rate (eGFR, calculated with 
CKD-EPI formulae [13]), procedures, cardiopulmonary bypass (CPB) duration, and 
erythrocyte transfusion amount on the day of surgery. Each unit of erythrocyte 
contains 300 mL. Full blood counts were measured from BD EDTA-K2 samples 
using a Sysmex XN9000 electronic counter. Both preoperative and post-operative 
RDW were collected and changes of RDW was defined as the difference between 
preoperative RDW and RDW measured 24 h after cardiac surgery. The reference 
range of RDW value was 11.0–16.0% in this hospital. If there were more than one 
cardiac surgery procedures performed during a single hospitalization, only the data on 
the first surgery was included in the analysis.  
The primary end-point was postoperative AKI. AKI was defined according to the 
KDIGO guideline [14] as any of the following: increase in SCr by ≥ 0.3 mg/dL (≥ 
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26.5 μmol/L) within 48 h; or increase in SCr to ≥ 1.5 times the baseline that is known 
or presumed to have occurred within the prior 7 days or urine volume < 0.5 mL/kg/h 
for 6 h.  
 
Statistical analyses 
Statistical analyses were performed by SPSS statistics for Windows (Version 
25.0. IBM Corp, Armonk, NY). Continuous variables were expressed as the mean ± 
standard deviation (SD) and analyzed by unpaired t-tests, with the Welch adjustment 
when necessary. Continuous variables that violated the normality assumption were 
expressed as median and 25th to 75th percentiles and analyzed by the Mann-Whitney 
U test. Categorical variables were expressed as absolute (n) and relative (%) 
frequency and were analyzed by the Pearson 2-test or the Fisher exact test whenever 
appropriate. A significant level was considered p < 0.05. 
Univariate analyses were performed to identify a potential association with 
CSAKI and those with p < 0.05 were entered into multivariate regression analysis to 
identify independent risk factors for both end-points. An adjusted logistic regression 
model was developed with variables that showed p < 0.05 in univariate analysis. 
Subgroup analysis was performed to elucidate the impact of erythrocyte 
transfusion on the prognostic role of elevated RDW for CSAKI. Patients were 
classified into two groups according  to whether receiving transfusions or not. 
Multivariable regressions were performed to identify the predictive role of elevated 
RDW for CSAKI in both subsets. 
 
RESULTS 
Baseline characteristics  
A total of 3207 eligible patients who underwent cardiac surgery during 2016–
2017 were enrolled in this cohort study.  Characteristics of patients are presented in 
Table 1. The CSAKI rate in the entire cohort was 38.07% (1221/3207). Among AKI 
patients, the incidence of stage 1, 2 and 3 were 72.9% (890/1221), 17.5% (214/1221) 
and 9.6% (117/1221). Male, elder, and those who had more comorbidities such as 
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hypertension and impaired preoperative cardiac and renal function were likely to 
develop CSAKI. Those patients who underwent complex surgery with multiple 
procedures or CPB were more inclined to develop CSAKI as well. However, patients 
in the present study were classified as undergoing valve surgery and no significant 
relation was found between the occurrence of CSAKI and multidirectional surgery 
types. The postoperative RDW and elevated RDW were higher in patients who 
developed CSAKI. Moreover, AKI patients received more RBC transfusions. The in-
hospital mortality (2.8 vs. 0.2%, p < 0.001) and length of stay (14 vs. 13%, p < 0.001) 
of CSAKI patients were significantly higher as well (Table 1). The magnitude of 
elevated RDW were higher in patients who received RBC transfusions, regardless of 
the occurrence of AKI. However, no significant trend of elevated RDW between 
different RBC transfusion groups was found (Fig. 1). 
 
Predictors for CSAKI 
Univariate analysis was performed to identify potential risk factors associated 
with CSA-AKI from the variables that showed a p value < 0.05 in Table 1. Male 
gender (odds ratio [OR]:1.596, 95% CI 1.375–1.852), age (per year) (OR: 1.030, 95% 
CI 1.024–1.037), preoperative hypertension (OR: 1.288, 95% CI 1.108–1.497), 
NYHA classification 3–4 (OR: 1.407, 95% CI 1.215–1.629), preoperative eGFR < 60 
mL/min/1.73 m2 (OR: 2.399, 95% CI 1.851–3.108), complex procedure (OR: 2.752, 
95% CI 2.001–3.784), CPB time > 120 min (OR: 2.134, 95% CI 1.752–2.599), 
erythrocyte transfusion (per unit) (OR: 1.340, 95% CI 1.243–1.445) and elevated 
RDW (OR: 1.335, 95% CI 1.232–1.447) were identified as potential predictors for 
CSAKI (Table 2).  
Multivariate regression was developed with variables that showed a p < 0.05 in 
the univariate analysis. Male gender (OR: 2.127, 95% CI 1.759–2.571), age (per year) 
(OR: 1.033, 95% CI 1.024–1.042), NYHA classification 3–4 (OR: 1.214, 95% CI 
1.002–1.471), preoperative eGFR < 60 mL/min/1.73 m2 (OR: 1.602, 95% CI 1.124–
2.284), CPB time > 120 min (OR: 1.919, 95% CI 1.553–2.372), erythrocyte 
transfusion (per unit) (OR: 1.167, 95% CI 1.056–1.289) and elevated RDW (OR: 
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1.108, 95% CI 1.005–1.222) were identified as independent predictors for CSAKI 
(Table 2).  
 
Subgroup analysis 
Patients were classified into two groups by whether they received transfusions or 
not. The CSAKI rate of the transfused patients was higher than the non-transfused 
(46.9 vs. 33.8%, p < 0.001). 
Multivariate regression was performed in both subgroups and showed elevated 
RDW was associated with CSAKI (OR: 1.613, p < 0.001) in the non-transfused group 
whereas no significance between the elevated RDW and CSAKI (p = 0.497) was 
found in the transfused subgroup (Table 3). 
The proportion of valve surgery is higher in Chinese patients undergoing heart 
surgery.  A subgroup analysis was performed of patients undergoing valve surgery   
finding no significant correlation between e-RDW and CSAKI in patients undergoing 
blood transfusion, while increased e-RDW was a risk factor for CSAKI in non-
transfused patients (OR: 1.877) (Table 4). 
 
Discussion 
The current study found that patients who developed CSAKI were more male, 
elderly and had more comorbidities. The magnitude of elevated RDW and erythrocyte 
transfusion were significantly higher in those who developed CSAKI as well. In the 
entire cohort and non-transfused subgroup, the elevated RDW was identified as 
independent predictor for CSAKI whereas a similar association was not validated in 
the transfused subgroup. 
Although extensive research has been carried out on the prognostic role of RDW, 
no single study exists which reports transfusion data or includes transfusion patients 
[9, 15–17]. According to available research, this is the first study describing the effect 
of transfusion on the prognostic role of RDW in cardiac surgery patients.  
 Elevated RDW may indicate several pathogeneses during perioperative phases. 
First, elevated RDW was reported to be associated with systemic inflammatory 
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response and proinflammatory cytokines during CPB surgery [8, 9]. Second, RDW 
increases when the number of erythrocytes in which hemoglobin is incompletely 
saturated with oxygen [18]. Finally, an increase of RDW reflects the increase in 
variation of erythrocyte size caused by oxidative stress [19]. 
Recent evidence has shown a relationship between RDW and acute kidney injury 
or its outcome [6, 7, 16]. In a previous study, the elevated RDW was indicated as an 
independent prognostic factor for severity and poor prognosis of CS-AKI [7]. 
However, transfusion characteristics were not reported. The results in the current 
study showed a consistent interpretation of elevated RDW associating with CSAKI in 
the entire cohort and non-transfused patients whereas a similar association was not 
validated in patients receiving erythrocyte transfusion. One possible explanation was 
that the role of elevated RDW indicating intraoperative inflammatory response and 
oxidative stress was predominant in non-transfused patients whereas an identical role 
was inferior as elevated RDW can be attributed to erythrocyte transfusion, which was 
reported as another predictor for CSAKI [11].  
A prior study noted the incremental effect of erythrocyte transfusion on RDW 
[12]. This elevated RDW was detectable immediately after transfusion and reached its 
highest value at 24 h after RBC transfusion. In the current study, the change of RDW 
was defined as the difference between RDW measured 24 h after cardiac surgery and 
preoperative RDW. If a patient received multiple numbers of RBC transfusion within 
the observation period, the cumulative increment of RDW by RBC transfusion will 
confound its prognostic role. In the transfused subgroup, each unit of erythrocyte 
transfusion increased 19.8% the risk of CSAKI. Accordingly, the analogous spectrum 
of ORs (1.08–1.26) for each unit of transfusion were reported in several studies 
indicating a solid association between erythrocyte transfusion and AKI [20–23]. 
There were several limitations in this study. First, it was a single-center 
retrospective study. Second, hematopoietic factors were not available in the study 
population, as it was not routinely tested in the cardiac surgery population. Finally, 
inflammatory cytokines and biomarkers were not measured in the present study. 
Therefore, the potential association between the severity of inflammation or oxidative 
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stress and elevated RDW was not quantizable.  
 
Conclusions 
In summary, the current study indicated that elevated RDW was associated with 
the onset of CSAKI in non-transfused cardiac surgery patients. A similar prognostic 
role of RDW was not valid in transfused patients due to the increment effect of 
transfusion on RDW. This confounding influence shall be considered in further 
studies evaluating the role of RDW. 
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Table 1. Perioperative patient characteristics of the study population. 
Characteristics 
Without AKI (n 
= 1986) 




Male 1121 (56.4%) 823 (67.4%) < 0.001 
Age [years] 55.21 ± 12.68 59.22 ± 10.92 < 0.001 
Medical history    
Hypertension 619 (31.2%) 450 (36.9%) < 0.001 
Diabetes mellitus 214 (10.8%) 148 (12.1%) 0.244 
NYHA classification 3–4 1108 (55.8%) 781 (64.0%) < 0.001 
Laboratory index    
Hemoglobin [g/L] 133.54 ± 14.98 134 ± 15.99 0.419 
Albumin [g/L] 39.83 ± 3.10 39.62 ± 3.21 0.071 
Pre-op RDW [%] 13.43 ± 1.32 13.48 ± 1.28 0.187 
Post-op RDW [%] 13.79 ± 1.60 14.13 ± 1.55 < 0.001 
Elevated RDW [%] 0.39 ± 0.22 0.65 ± 0.23 < 0.001 
Kidney function    
Serum creatinine [μmol/L] 76.84 ± 19.31 84.83 ± 31 < 0.001 
eGFR [mL/min/1.73 m2] 90.99 ± 21.42 84.86 ± 22.98 < 0.001 
Procedure    
Isolated valve 1271 (64.0%) 717 (58.7%) 0.003 
Single valve surgery:    
AVR 374 (18.83%) 158 (12.94%) 0.106 
MVP 187 (9.41%) 120 (9.82%) 0.981 
MVR 148 (7.45%) 146 (11.95%) 0.225 
Double valve surgery:    
AVR+MVP 11 (0.56%) 35 (2.86%) 0.078 
DVR 146 (7.35%) 69 (5.65%) 0.498 
MVR+TVP 157 (7.90%) 65 (5.32%) 0.497 
Triple valve surgery:    
AVR+MVR+TVP 110 (5.53%) 104 (8.50%) 0.355 
Others 138 (6.94%) 20 (1.63%) 0.588 
Minimal invasive valve surgery 128 (6.44%) 72 (5.89%) 0.974 
Isolated CABG 650 (32.7%) 400 (32.8%) 0.986 
Valve and CABG 65 (3.3%) 104 (8.5%) < 0.001 
CPB time [min] 93.61 ± 30.58 110.82 ± 36.39 < 0.001 
Erythrocyte transfusion**    
0 U 1427 (71.9%) 728 (59.6%) < 0.001 
1 U 397 (20.0%) 303 (24.8%) 0.001 
2 U 39 (2.0%) 52 (4.3%) < 0.001 
3 U 107 (5.4%) 105 (8.6%) < 0.001 
4 U 16 (0.8%) 33 (2.7%) < 0.001 
Prognosis    
In-hospital mortality 4 (0.2%) 34 (2.8%) < 0.001 
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Length of hospital stay 13 (10–16) 14 (11–18) < 0.001 
The values are expressed as the median (interquartile range) and mean ± standard deviation or number 
(percentage). P-values are the results of unpaired t-test or Mann–Whitney U test for continuous 
variables, and χ2 test or Fisher’s exact test for categorical variables. *Other procedures include tricuspid 
valve surgery, repairment of paraprosthetic regurgitation. **The number of erythrocyte transfusion 
refers to the number of the transfusion on the day of surgery. AKI — acute kidney injury; AVR — 
aortic valve replacement; CABG — coronary artery bypass grafting; CPB — cardiopulmonary bypass; 
DVR — aortic valve replacement and mitral valve replacement; eGFR — estimated glomerular 
filtration rate, calculated by CKD-EPI formulae; MVP — mitral valve plasty; MVR — mitral valve 
replacement; NYHA — New York Heart Association; RDW — red cell distribution width; TVP — 




Table 2. Analysis of risk factors for CSAKI in entire cohort. 
Variables 
Unadjusted Adjusted 
OR 95% CI P OR 95% CI P 
Male 1.596 1.375–1.852 < 0.001 2.127 1.759–2.571 < 0.001 
Age [years] 1.030 1.024–1.037 < 0.001 1.033 1.024–1.042 < 0.001 
Hypertension 1.288 1.108–1.497 < 0.001    
NYHA classification 
3–4 
1.407 1.215–1.629 < 0.001 1.214 1.002–1.471 0.048 
Elevated RDW (%) 1.335 1.232–1.447 < 0.001 1.108 1.005–1.222 0.039 
eGFR < 60 
ml/min/1.73 m2 
2.399 1.851–3.108 < 0.001 1.602 1.124–2.284 0.009 
Valve + CABG 2.752 2.001–3.784 < 0.001    
CPB time > 120 min 2.134 1.752–2.599 < 0.001 1.919 1.553–2.372 < 0.001 
Erythrocyte transfusion 
(units) * 
1.340 1.243–1.445 < 0.001 1.167 1.056–1.289 0.002 
*The number of erythrocyte transfusion refers to the number of the transfusion on the day of surgery. CABG —coronary artery bypass grafting; CSAKI — cardiac surgery 
associated acute kidney injury; CPB — cardiopulmonary bypass; eGFR — estimated glomerular filtration rate, calculated by CKD-EPI formulae; NYHA — New York Heart 
Association; OR — odds ratio; RDW — red cell distribution width 
 
 
Table 3. Subgroup analysis of risk factors for CSAKI. 
Variables 
Transfusion Non-transfusion 
OR 95% CI P OR 95% CI P 
Male 2.130 1.582–2.866 < 0.001 2.216 1.722–2.850 < 0.001 
Age [years] 1.030 1.016–1.044 < 0.001 1.035 1.024–1.047 < 0.001 




CPB time > 120 min 2.251 1.631–3.107 < 0.001 1.675 1.257–2.232 < 0.001 
NYHA classification 3-4 1.384 1.004–1.909 0.047    
Erythrocyte transfusion 
[U]* 
1.198 1.028–1.391 0.021    
Elevated RDW 1.040 0.928–1.167 0.497 (NS) 1.613 1.277–2.037 < 0.001 
*The number of erythrocyte transfusion refers to the number of the transfusion on the day of surgery. CSAKI — cardiac surgery associated acute kidney injury; CPB —
cardiopulmonary bypass; eGFR — estimated glomerular filtration rate, calculated by CKD-EPI formulae; NYHA — New York Heart Association; OR — odds ratio; RDW 
— red cell distribution width; NS — not significant 
 
 
Table 4. Subgroup analysis of risk factors for CSAKI in patients underwent valve surgery. 
Variables 
Transfusion Non-transfusion 
OR 95% CI P OR 95% CI P 
Male 1.035 1.020–1.051 < 0.001 1.037 1.025–1.048 < 0.001 
Age [years] 1.873 1.355–2.587 < 0.001 2.194 1.703–2.826 < 0.001 
NYHA classification 3–
4 
1.430 1.009–2.026 0.045 1.386 1.079–1.781 0.011 
Erythrocyte transfusion 
[U]* 
1.194 1.006–1.417 0.042    
Elevated RDW   0.314 (NS) 1.877 1.470–2.397 < 0.001 
*The number of erythrocyte transfusion refers to the number of the transfusion on the day of surgery. CSAKI — cardiac surgery associated acute kidney injury; NYHA — 
New York Heart Association; OR — odds ratio; RDW — red cell distribution width; NS — not significant 
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Figure 1. The magnitude of elevated red cell distribution width (eRDW) between 
different transfusion amount in both acute kidney injury (AKI) and non-AKI 
subgroups; *p < 0.001; NS — not significant. 
 
 
 
 
